George Yancopoulos (L) and Len Schleifer (Regeneron)

Re­gen­eron co-founders slow down com­pen­sa­tion in 2021, net­ting just $13M com­bined af­ter $270M in 2020

Af­ter Re­gen­eron’s co-founders cleared 2020 with a po­ten­tial $260 mil­lion in stock awards that could be cashed out in a few years, the to­tal salary for the pair of bil­lion­aires has come down from its sky high perch.

CEO Len Schleifer and CSO George Yan­copou­los, the pair at the fore­front of the 34-year-old phar­ma, each earned ap­prox­i­mate­ly $6.4 mil­lion in 2021, putting them on the low side of CEO and top ex­ec pay­outs in their in­dus­try. And for Amer­i­can phar­mas, it puts the pair even low­er on the pay totem pole com­pared to sub­stan­tial­ly larg­er phar­ma com­pa­nies like J&J. Alex Gorsky, the for­mer CEO and now ex­ec­u­tive chair­man, brought in more than $26 mil­lion in pay and perks for 2021.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.